Dry Eyes (Keratoconjunctivitis Sicca)

Key Takeaways

• Dry eyes occur when tears fail to provide adequate lubrication, either due to insufficient tear production or excessive tear evaporation
• Common symptoms include stinging, burning, redness, light sensitivity, and paradoxical watery eyes
• Risk factors include aging, female gender, prolonged screen use, certain medications, and environmental conditions
• Treatment ranges from artificial tears and lifestyle modifications to prescription medications and procedural interventions
• Most cases are manageable with appropriate treatment, though chronic dry eye requires ongoing management
• Proper nursing assessment includes tear film evaluation, symptom severity scoring, and monitoring for corneal complications

Overview

Dry eye disease represents one of the most prevalent ocular surface disorders affecting millions globally. This multifactorial condition results from instability of the tear film, leading to ocular discomfort, visual disturbance, and potential damage to the ocular surface. The prevalence increases with age, particularly affecting individuals over 50 years, with women experiencing higher rates than men. Understanding dry eyes requires recognizing the complex interplay between tear production, tear composition, and environmental factors that maintain ocular surface health.

What is Dry Eyes?

Dry eyes is a chronic condition characterized by insufficient tear film quality or quantity to maintain the health and comfort of the ocular surface. The tear film consists of three layers: an outer lipid layer that prevents evaporation, a middle aqueous layer providing moisture and nutrients, and an inner mucin layer that helps tears adhere to the eye surface. When any component becomes deficient or imbalanced, the protective tear film breaks down rapidly, exposing the corneal and conjunctival surfaces to damage and irritation.

The condition manifests in two primary forms: aqueous-deficient dry eye, where lacrimal glands produce insufficient tears, and evaporative dry eye, where tears evaporate too quickly due to lipid layer dysfunction. Many patients experience a combination of both types. The Tear Film and Ocular Surface Society defines dry eye disease as a multifactorial disorder involving loss of tear film homeostasis, accompanied by ocular symptoms with inflammation, damage, and neurosensory abnormalities playing etiological roles.

Symptoms

The clinical presentation of dry eyes varies considerably among patients, ranging from mild intermittent discomfort to severe debilitating symptoms affecting daily activities and quality of life.

Common Symptoms:

• Persistent scratchy or gritty sensation, as if sand or foreign material is in the eye
• Burning or stinging sensation that worsens throughout the day
• Redness and inflammation of the conjunctiva and eyelid margins
• Blurred vision or visual fluctuations, particularly during reading or screen use
• Excessive tearing (reflex tearing) as the eye attempts to compensate for dryness
• Eye fatigue and difficulty keeping eyes open
• Mucus discharge, especially upon waking
• Light sensitivity (photophobia) in moderate to severe cases
• Difficulty wearing contact lenses or reduced tolerance time
• Sensation of heavy eyelids or difficulty with prolonged visual tasks

Symptoms typically worsen in dry environments, during prolonged visual concentration, in air-conditioned or heated spaces, with wind exposure, and in low humidity conditions. Many patients report symptom improvement after sleep when eyes remain closed and protected.

Causes and Risk Factors

Dry eyes results from multiple contributing factors that disrupt normal tear film physiology. Understanding these factors helps identify at-risk individuals and implement preventive strategies.

Primary Causes:

• Reduced tear production: Age-related decline in lacrimal gland function, autoimmune destruction of lacrimal tissue (Sjögren syndrome), or congenital alacrima
• Increased tear evaporation: Meibomian gland dysfunction leading to lipid layer deficiency, incomplete eyelid closure (lagophthalmos), or reduced blink rate
• Inflammatory processes: Ocular surface inflammation triggered by environmental irritants, allergens, or autoimmune responses
• Tear film instability: Imbalanced tear composition affecting mucin or aqueous layers

Risk Factors:

• Advanced age, particularly beyond 50 years when tear production naturally declines
• Female gender due to hormonal influences on tear glands
• Hormonal changes during pregnancy, oral contraceptive use, or menopause
• Prolonged digital device use with reduced blink frequency (computer vision syndrome)
• Contact lens wear, especially extended or overnight use
• Environmental factors including low humidity, air conditioning, heating systems, wind, smoke, and air pollution
• Systemic medications including antihistamines, decongestants, antidepressants, beta-blockers, diuretics, and isotretinoin
• Autoimmune conditions such as Sjögren syndrome, rheumatoid arthritis, lupus, and scleroderma
• Previous ocular surgery, particularly LASIK and other refractive procedures
• Eyelid abnormalities including incomplete closure, ectropion, or entropion
• Vitamin A deficiency affecting goblet cell function
• Chronic blepharitis or meibomian gland dysfunction
• Neurological conditions affecting blink reflex or eyelid function
• Radiation therapy to the head or neck region

Diagnosis

Diagnosis of dry eyes involves comprehensive clinical evaluation combining patient history, symptom assessment, and objective testing to determine severity and underlying etiology.

Clinical Assessment:

• Patient history: Detailed symptom characterization including onset, duration, severity, aggravating and relieving factors
• Medication review: Identification of systemic and topical medications that reduce tear production
• Systemic disease screening: Assessment for autoimmune disorders, diabetes, thyroid disease
• Occupational and environmental exposure: Evaluation of screen time, workplace conditions, climate factors

Diagnostic Tests:

• Slit-lamp biomicroscopy: Direct visualization of tear film quality, corneal and conjunctival surface integrity, eyelid margins, and meibomian gland orifices
• Tear breakup time (TBUT): Measurement of tear film stability using fluorescein dye; values below 10 seconds indicate instability
• Schirmer test: Quantification of tear production using standardized filter paper strips placed in lower conjunctival sac; less than 10mm wetting after 5 minutes suggests aqueous deficiency
• Ocular surface staining: Fluorescein or lissamine green dye application to identify corneal and conjunctival epithelial damage
• Meibomian gland assessment: Expression of glands to evaluate secretion quality and quantity
• Tear osmolarity testing: Measurement of tear salt concentration; elevated osmolarity indicates dry eye
• Matrix metalloproteinase-9 (MMP-9) testing: Point-of-care inflammatory marker detection
• Tear meniscus height: Assessment of tear volume along lower eyelid margin
• Symptom questionnaires: Standardized tools such as Ocular Surface Disease Index (OSDI) or Dry Eye Questionnaire (DEQ-5)

Differential Diagnoses

Several ocular conditions present with symptoms similar to dry eyes, requiring careful differentiation:

• Allergic conjunctivitis: Distinguished by intense itching, bilateral presentation, and seasonal pattern
• Infectious conjunctivitis: Characterized by purulent discharge, acute onset, and contagious nature
• Anterior uveitis: Presents with pain, photophobia, and ciliary flush requiring urgent treatment
• Corneal abrasion or foreign body: Sudden onset, unilateral presentation, history of trauma
• Blepharitis: Eyelid margin inflammation with crusting and collarettes, often coexists with dry eye
• Glaucoma medications side effects: Preservative-induced toxicity mimicking dry eye symptoms
• Pterygium or pinguecula: Visible conjunctival growths causing irritation
• Chronic pain syndromes: Neuropathic ocular pain with normal tear parameters

Types of Dry Eyes

Dry eye disease is classified into distinct subtypes based on underlying pathophysiology, though many patients exhibit mixed presentations.

Aqueous-Deficient Dry Eye:

• Results from inadequate tear production by lacrimal glands
• Associated with Sjögren syndrome (autoimmune), non-Sjögren syndrome causes, lacrimal gland dysfunction, or reflex secretory block
• Characterized by low Schirmer test values and reduced tear meniscus height

Evaporative Dry Eye:

• Caused by excessive tear evaporation despite normal production
• Most commonly due to meibomian gland dysfunction (MGD) with inadequate lipid secretion
• Other causes include low blink rate, eyelid aperture abnormalities, contact lens wear, and ocular surface disorders affecting mucin layer

Mixed Mechanism Dry Eye:

• Combination of aqueous deficiency and evaporative components
• Represents the most common clinical presentation
• Requires comprehensive treatment addressing multiple pathophysiological mechanisms

Sjögren Syndrome-Associated Dry Eye:

• Autoimmune condition causing lymphocytic infiltration of lacrimal and salivary glands
• Primary Sjögren occurs independently; secondary Sjögren accompanies other autoimmune diseases
• Presents with severe dry eye alongside dry mouth (xerostomia) and systemic manifestations

Treatment Options

Management of dry eyes employs a stepwise approach tailored to severity, underlying cause, and patient response, progressing from conservative measures to advanced interventions.

First-Line Treatments:

• Artificial tears: Over-the-counter lubricating drops providing temporary symptom relief; preservative-free formulations preferred for frequent use (more than 4 times daily)
• Lubricating ointments: Thicker preparations for nighttime use providing prolonged ocular surface protection
• Eyelid hygiene: Warm compresses and lid massage to improve meibomian gland function and reduce inflammation
• Environmental modifications: Humidifiers, reducing air conditioning or heating exposure, positioning away from direct airflow, taking screen breaks
• Omega-3 fatty acid supplementation: Dietary intake or supplements to reduce ocular surface inflammation and improve meibomian gland secretion quality

Second-Line Treatments:

• Prescription anti-inflammatory medications: Cyclosporine ophthalmic emulsion 0.05% or 0.09% to increase tear production by reducing inflammation; lifitegrast 5% targeting lymphocyte function-associated antigen-1
• Prescription tear stimulation: Varenicline nasal spray to stimulate natural tear production
• Topical corticosteroids: Short-term use for acute exacerbations under ophthalmology supervision
• Punctal occlusion: Temporary or permanent plugs inserted into tear drainage ducts to retain tears on ocular surface
• Scleral or specialty contact lenses: For severe cases, creating fluid reservoir over cornea
• Autologous serum eye drops: Prepared from patient’s own blood, providing growth factors and nutrients

Advanced Treatments:

• Intense pulsed light (IPL) therapy: For meibomian gland dysfunction, using light energy to improve gland function
• LipiFlow thermal pulsation: Automated device applying heat and pressure to express meibomian glands
• Amniotic membrane therapy: Biological dressing promoting healing in severe cases
• Systemic immunosuppression: For Sjögren syndrome or severe autoimmune-related dry eye
• Surgical interventions: Tarsorrhaphy (partial eyelid closure), salivary gland transplantation in refractory cases

Lifestyle and Supportive Measures:

• Frequent blinking exercises during prolonged visual tasks
• 20-20-20 rule: every 20 minutes, look 20 feet away for 20 seconds
• Protective eyewear in windy or dusty environments
• Adequate hydration
• Discontinuation or substitution of contributing medications when possible
• Optimal contact lens hygiene or temporary cessation

Possible Complications

Untreated or poorly managed dry eyes can progress to serious complications affecting vision and ocular health.

Ocular Surface Complications:

• Corneal epithelial defects: Breakdown of protective corneal surface layer causing pain and infection risk
• Corneal ulceration: Deep corneal tissue damage potentially leading to scarring and vision loss
• Corneal neovascularization: Abnormal blood vessel growth into normally avascular cornea
• Corneal scarring: Permanent opacity affecting visual clarity
• Infectious keratitis: Bacterial, viral, or fungal corneal infection facilitated by compromised epithelial barrier
• Conjunctival scarring: Chronic inflammation leading to fibrosis and symblepharon formation
• Filamentary keratitis: Formation of mucus strands attached to corneal surface causing severe discomfort

Functional Complications:

• Progressive visual impairment affecting reading, driving, and occupational performance
• Chronic pain and discomfort reducing quality of life
• Recurrent corneal erosions with acute pain episodes
• Contact lens intolerance limiting corrective options
• Increased risk of surgical complications during intraocular procedures
• Psychological impact including depression and anxiety related to chronic symptoms

Severe Cases:

• Corneal perforation in extreme neglect requiring urgent surgical intervention
• Permanent vision loss from corneal scarring or infection
• Secondary glaucoma from chronic inflammation or surgical interventions

Prevention

While not all dry eye cases are preventable, particularly those related to aging or systemic disease, many risk factors can be modified to reduce incidence and severity.

Primary Prevention Strategies:

• Regular screen breaks and conscious blinking during computer work
• Maintaining adequate indoor humidity levels between 30-50%
• Positioning workstations to avoid direct overhead air vents or fans
• Wearing wraparound sunglasses or protective eyewear outdoors in windy conditions
• Staying well-hydrated with adequate daily fluid intake
• Consuming omega-3 rich foods including fatty fish, flaxseed, and walnuts
• Avoiding smoking and secondhand smoke exposure
• Regular eyelid hygiene to prevent meibomian gland dysfunction

Secondary Prevention:

• Early treatment of blepharitis or meibomian gland dysfunction before progression
• Prompt management of systemic conditions affecting tear production
• Regular ophthalmology follow-up for high-risk individuals
• Preservative-free artificial tears for patients requiring frequent lubrication
• Appropriate contact lens wear schedule with daily removal and cleaning
• Medication review with healthcare provider to identify alternatives to tear-reducing drugs

Occupational Considerations:

• Ergonomic workspace setup with monitor positioned below eye level to reduce lid aperture
• Scheduled breaks from visually demanding tasks
• Environmental controls in workplace settings
• Education for workers in high-risk industries regarding protective measures

Prognosis and Outlook

The prognosis for dry eyes varies based on underlying etiology, severity at presentation, treatment adherence, and modifiable risk factors.

Mild to Moderate Cases:

Most patients with mild to moderate dry eyes achieve satisfactory symptom control through conservative management including artificial tears, environmental modifications, and eyelid hygiene. Symptoms may fluctuate with environmental conditions, general health status, and medication changes but rarely progress to vision-threatening complications. Quality of life typically improves significantly with appropriate treatment, though ongoing maintenance therapy is usually required.

Severe or Autoimmune-Related Cases:

Patients with severe aqueous-deficient dry eye, particularly those with Sjögren syndrome, face more challenging management requiring lifelong treatment and close monitoring. While complete cure is uncommon, modern therapeutic options including anti-inflammatory medications and procedural interventions can substantially reduce symptoms and prevent complications. Regular ophthalmology follow-up is essential for detecting early signs of corneal damage.

Factors Affecting Prognosis:

• Early diagnosis and treatment initiation improve outcomes significantly
• Treatment adherence and patient engagement in lifestyle modifications
• Control of underlying systemic diseases
• Avoidance of environmental triggers
• Regular professional monitoring and treatment adjustment

Long-Term Outlook:

With appropriate management, most patients maintain functional vision and acceptable comfort levels throughout life. Advances in treatment options continue to expand, offering improved outcomes even for previously refractory cases. However, dry eye disease typically requires ongoing management rather than achieving permanent resolution, particularly in older adults and those with systemic risk factors.

Nursing Care Plan for Patients with Dry Eyes

Nursing Assessment

Comprehensive nursing assessment establishes baseline severity and guides individualized care planning.

Subjective Assessment:

• Detailed symptom characterization including severity scale (0-10), frequency, duration, and impact on daily activities
• Identification of aggravating factors such as environmental conditions, activities, time of day
• Relieving factors including rest, eye closure, artificial tear use
• Current medication regimen including over-the-counter and prescription eye drops
• Compliance barriers such as cost, forgetfulness, difficulty with drop instillation
• Psychosocial impact on work performance, hobbies, and quality of life
• Patient understanding of condition and treatment rationale

Objective Assessment:

• Visual acuity testing to establish baseline and detect changes
• External eye examination noting redness, discharge, eyelid abnormalities
• Observation of blink rate and completeness during conversation
• Tear film adequacy assessment through observation of tear meniscus
• Documentation of any corneal or conjunctival staining patterns reported in clinical records
• Medication administration technique observation for proper drop instillation
• Identification of environmental factors in home or workplace

Ongoing Monitoring:

• Symptom severity tracking using standardized questionnaires at each visit
• Treatment response and side effect evaluation
• Compliance assessment with prescribed regimen
• Early detection of complications requiring escalation
• Quality of life impact measurement

Nursing Interventions

Nursing interventions focus on symptom management, treatment optimization, patient education, and complication prevention.

Direct Care Interventions:

• Demonstrate proper artificial tear and medication instillation technique ensuring patient understanding
• Teach eyelid hygiene routine including warm compress application (10-15 minutes, twice daily) and gentle lid massage
• Administer prescribed medications during inpatient care, noting response and adverse effects
• Provide eye protection strategies during procedures or exposure to irritants
• Facilitate punctal plug insertion procedures and monitor for displacement or complications

Patient Education:

• Explain dry eye pathophysiology in understandable terms to improve treatment adherence
• Provide written instructions for medication regimen including timing, frequency, and proper storage
• Teach environmental modification strategies including humidifier use, workspace ergonomics, and protective eyewear
• Educate on distinguishing routine symptoms from concerning signs requiring medical attention
• Discuss dietary considerations emphasizing omega-3 fatty acid sources
• Review contact lens care protocols or recommend temporary cessation if applicable
• Reinforce importance of medication adherence and consistent follow-up

Supportive Interventions:

• Assist with identifying and addressing compliance barriers such as cost concerns or physical limitations
• Provide emotional support for patients experiencing quality of life impacts
• Coordinate referrals to ophthalmology, rheumatology, or other specialists as indicated
• Connect patients with support groups or educational resources
• Document patient progress and communicate with interdisciplinary team

Environmental Management:

• Assess home and workplace environments for modifiable risk factors
• Recommend practical modifications such as humidifier placement, air purifier use
• Suggest positional changes to avoid direct air currents
• Educate on screen time management and break scheduling

Nursing Evaluation

Systematic evaluation determines treatment effectiveness and guides care plan modifications.

Outcome Evaluation Criteria:

• Symptom severity reduction measured through validated questionnaires or patient-reported scales
• Improved ability to perform daily activities without ocular discomfort
• Proper medication administration technique demonstrated consistently
• Environmental modifications successfully implemented
• Absence of complications such as corneal damage or infection
• Patient verbalization of understanding regarding condition and treatment
• Treatment adherence maintained with barriers addressed
• Stable or improved visual acuity measurements
• Patient satisfaction with symptom control and quality of life

Indicators of Successful Management:

• Patient reports decreased frequency and severity of burning, stinging, or grittiness
• Reduced reliance on artificial tears or achievement of stable maintenance regimen
• Ability to complete work tasks, reading, or screen use without significant disruption
• No evidence of corneal epithelial defects or conjunctival inflammation on examination
• Patient demonstrates proper self-care techniques independently

Need for Care Plan Revision:

• Persistent or worsening symptoms despite treatment adherence
• Development of complications requiring intervention escalation
• Identification of new barriers to treatment compliance
• Changes in patient condition or medication regimen affecting dry eye status
• Patient request for alternative treatment approaches

In Clinical Practice

Managing patients with dry eyes requires balancing evidence-based interventions with individualized approaches that address each patient’s unique circumstances and challenges.

Practical Considerations:

Patients often underestimate the chronic nature of dry eye disease, expecting rapid resolution. Setting realistic expectations early prevents frustration and improves adherence. Explaining that dry eyes typically require ongoing management similar to other chronic conditions helps patients understand the importance of consistent treatment rather than intermittent use only when symptoms worsen.

Environmental assessment proves invaluable for identifying modifiable factors. Many patients work in air-conditioned offices, spend hours on digital devices, or live in low-humidity climates without recognizing these as significant contributors. Simple interventions like repositioning desks away from air vents, using desktop humidifiers, or applying warm compresses before bedtime often provide substantial relief when combined with medical treatment.

Cost concerns frequently affect medication adherence, particularly with prescription anti-inflammatory drops. Exploring patient assistance programs, generic alternatives, or starting with over-the-counter preservative-free tears can bridge financial gaps while maintaining treatment effectiveness. Some patients benefit from purchasing artificial tears in bulk or using nighttime ointments to reduce daytime drop frequency.

Patient Education Challenges:

Drop instillation technique significantly impacts treatment effectiveness. Many patients waste medication by missing the eye, contaminating dropper tips, or failing to wait adequate intervals between different drops. Demonstrating technique with saline, having patients practice with supervision, and providing written instructions with diagrams improves outcomes. Teaching the head-tilt-back method or lying supine for instillation helps patients with coordination difficulties.

Distinguishing routine dry eye symptoms from complications requiring urgent attention empowers patients to seek appropriate care timing. Educating patients to recognize warning signs including sudden vision changes, severe pain, copious discharge, or extreme light sensitivity prevents delays in treating serious complications while avoiding unnecessary emergency visits for typical symptom fluctuations.

Common Patient Concerns:

Patients frequently express concern about becoming dependent on artificial tears. Reassuring patients that lubricating drops do not cause dependency but rather provide necessary moisture helps alleviate this worry. Explaining that tears function like moisturizer for skin—providing needed hydration without negative effects—often resolves this misconception.

Paradoxical tearing confuses many patients who question why dry eyes cause excessive watering. Clarifying that damaged ocular surfaces trigger reflex tearing producing watery tears lacking protective components helps patients understand why treatment remains necessary despite tearing.

Interdisciplinary Collaboration:

Collaborating with ophthalmology, rheumatology, and primary care ensures comprehensive management, particularly for patients with systemic autoimmune conditions. Nurses serve as communication bridges between specialties, coordinating care plans and ensuring consistent messaging across providers.

Clinical Signs of Deterioration and When to Escalate

Recognizing early signs of dry eye complications enables timely intervention preventing vision loss and serious sequelae.

Immediate Escalation Required:

• Sudden significant vision loss or marked vision deterioration
• Severe eye pain not relieved by usual treatments
• Copious purulent discharge suggesting bacterial infection
• Visible corneal opacity or white spot on the cornea indicating ulceration
• Eye trauma or sensation of something embedded in the eye
• Extreme photophobia with inability to tolerate normal lighting
• Diffuse bright red eye with circumcorneal injection suggesting anterior uveitis
• Complete inability to open eye due to pain or swelling

Urgent Ophthalmology Referral Within 24 Hours:

• Progressive worsening of symptoms despite treatment adherence
• New onset of colored halos around lights suggesting corneal edema or elevated intraocular pressure
• Increasing redness unresponsive to treatment
• Development of light sensitivity interfering with daily activities
• Foreign body sensation persisting beyond 24 hours
• Recurrent morning eye pain suggesting corneal erosion
• Mucus strands visible on corneal surface (filamentary keratitis)
• Inability to wear contact lenses that were previously tolerated

Routine Escalation to Healthcare Provider:

• Symptoms inadequately controlled after 2-4 weeks of appropriate treatment
• Adverse reactions to prescribed medications including increased redness, burning, or vision changes
• New medications started that may worsen dry eyes
• Development of new systemic symptoms suggesting autoimmune disease (joint pain, dry mouth, fatigue)
• Persistent foreign body sensation requiring constant artificial tear use
• Difficulty maintaining treatment regimen due to side effects or practical barriers
• Patient concern about treatment effectiveness or desire for alternative approaches

Patient Education on Warning Signs:

Patients should seek immediate medical attention for sudden pain, vision loss, or discharge. They should contact their ophthalmologist within 24 hours for progressive worsening, new light sensitivity, or persistent foreign body sensation. Regular follow-up appointments should address inadequate symptom control, medication concerns, or new systemic symptoms potentially related to underlying conditions.

Documentation and Communication:

Nurses should thoroughly document symptom progression, treatment response, and any concerning findings in patient records. Clear communication with ophthalmology regarding symptom severity, impact on daily functioning, and patient concerns ensures appropriate prioritization and intervention timing. Standardized assessment tools facilitate objective tracking and enable early detection of deterioration trends.

Disclaimer: This content is provided for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional, taking into account the individual patient’s medical history, current condition, and applicable clinical guidelines. Always seek the advice of a physician or other qualified healthcare provider with any questions regarding a medical condition.